Next Quarterly Earnings
Tuesday, November 3, 2026
CW 45
Pre-Market
In 68 days
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Tonghua Dongbao Pharmaceutical A
Tonghua Dongbao Pharmaceutical A is a leading Chinese pharmaceutical company specializing in the research, production, and marketing of diabetes medications. Known as a pioneer in human insulin, the company drives continuous innovation within the fields of biotechnology and endocrinology.
Frequently asked questions
When will Tonghua Dongbao Pharmaceutical A report its next quarterly earnings?
Tonghua Dongbao Pharmaceutical A is scheduled to report its next quarterly earnings on 11/03/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
When did Tonghua Dongbao Pharmaceutical A last report quarterly earnings?
Tonghua Dongbao Pharmaceutical A last reported quarterly earnings on 8/25/2026 (Q2 2026). Earnings per share (EPS) came in at 0.09 CNY.
How often has Tonghua Dongbao Pharmaceutical A beaten expectations?
Tonghua Dongbao Pharmaceutical A has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
How do I add the Tonghua Dongbao Pharmaceutical A earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Estimates vs. results
2/5
Quarters above estimates
40%
Beat rate
+10.6%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Tonghua Dongbao Pharmaceutical A
Country
🇨🇳
More Financial Information